RealFeedApp China launched genetic treatment trials at a fraction of U.S. costs
Stricter government regulations and recent deaths in trials have caused the Huang foundation to pause plans for two additional clinical studies.
- Field
- medicine and diagnostics
- What they did
- Researchers in China faced an increase in clinical trials that were cancelled due to participant deaths and stricter government regulations.
- Why it matters
- This could be beneficial for patients with rare diseases, as the new rules are intended to make the trial registration and conduct process safer.
#clinical trial#genetic disease#china#regulation#rare disease
